We plan to look at the (anticipated) actual cost savings related to decreased vancomycin use (drug costs, laboratory costs, and pharmacy services related to vancomycin administration) versus the cost of the additional PCR testing.
We plan to look at the (anticipated) actual cost savings related to decreased vancomycin use (drug costs, laboratory costs, and pharmacy services related to vancomycin administration) versus the cost of the additional PCR testing.